InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Browse the full record of transactions filed by Anzalone Christopher Richard, Chief Executive Officer. Director active across 1 companies, notably Arrowhead Pharmaceuticals, INC.. Aggregated, 21 disclosures have been published. Total volume traded: €11m. The latest transaction was filed on 2 January 2026 — Cession. Regulator: SEC (Form 4). The full history is free.
Declarations21 total
US$415,7847,416 shares@ US$56.06590.0039% mcap7.2% of flow
Common Stock
SEC:0001423029-26-000001·
€415,7847,416 shares@ €56.06590.0039% mcap3.4% of flow
Common Stock
SEC:0001423029-26-000001:0·
US$183,78335,181 shares@ US$5.22390.0017% mcap3.2% of flow
Common Stock
SEC:0001423029-25-000009·
€183,78335,181 shares@ €5.22390.0017% mcap1.5% of flow
Common Stock
SEC:0001423029-25-000009:0·
US$226,2393,979 shares@ US$56.85820.0021% mcap3.9% of flow
Common Stock
SEC:0001423029-25-000007·
€226,2393,979 shares@ €56.85820.0021% mcap1.8% of flow
Common Stock
SEC:0001423029-25-000007:0·
US$3m46,287 shares@ US$54.08740.023% mcap43.1% of flow
Common Stock
SEC:0001423029-25-000005·
€3m46,287 shares@ €54.08740.023% mcap20.4% of flow
Common Stock
SEC:0001423029-25-000005:0·
0180,000 shares0
Common Stock
SEC:0001423029-25-000003·
0180,000 shares0
Common Stock
SEC:0001423029-25-000003:0·
€665,544146,388 shares@ €4.54640.0062% mcap5.4% of flow
Common Stock
SEC:0001209191-22-009052:0·
€54,23911,806 shares@ €4.59420.0005% mcap0.9% of flow
Common Stock
SEC:0001209191-22-002617·
€54,23911,806 shares@ €4.59420.0005% mcap0.4% of flow
Common Stock
SEC:0001209191-22-002617:0·
0800,000 shares0
Common Stock
SEC:0001209191-22-001284·
0800,000 shares0
Common Stock
SEC:0001209191-22-001284:0·
€54,08611,806 shares@ €4.58120.0005% mcap0.9% of flow
Common Stock
SEC:0001209191-21-071196·
€54,08611,806 shares@ €4.58120.0005% mcap0.4% of flow
Common Stock
SEC:0001209191-21-071196:0·
€2m25,857 shares@ €58.85660.014% mcap26.2% of flow
Common Stock
SEC:0001209191-21-070467·
€2m25,857 shares@ €58.85660.014% mcap12.4% of flow
Common Stock
SEC:0001209191-21-070467:0·
€852,38015,000 shares@ €56.82530.0079% mcap14.7% of flow
Common Stock
SEC:0001209191-21-061426·
€852,38015,000 shares@ €56.82530.0079% mcap6.9% of flow
Common Stock
SEC:0001209191-21-061426:0·
21 of 21 declarations
About Anzalone Christopher Richard
Anzalone Christopher Richard is the Chief Executive Officer of ARROWHEAD PHARMACEUTICALS, INC.
